Publication Beamlines Strategic Pillar
(2018). Anti-hemagglutinin antibodies and methods of use. Patent Number: IL263320A.
(2017). ANTI-BCMA ANTIBODIES (CELL MATURATION ANTIGEN B), BINDING SPECIFIC MOLECULES THAT JOIN BCMA AND CD3 (AGGREGATE DETERMINANT 3), AND USES OF THESE. Patent Number: AR105724A1.
(2021). Stable heterodimeric antibody design with mutations in the fc domain. Patent Number: PT2773671T.
(2015). Anti-hemagglutinin antibodies and methods of use. Patent Number: IL238684A0.
(2015). ANTIHEMAGLUTININE ANTIBODIES AND METHODS OF USE. Patent Number: AR093446A1.
(2020). ANTI-BCMA ANTIBODIES, BIESPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND THEIR USES. Patent Number: PT3337824T.
(2015). Novel TNFa structure for use in therapy. Patent Number: GB201510758D0.
(2007). News and Views: Mining Environmental Problems at the Canadian Light Source. Synchrotron Radiation News 20(3) . 10.1080/08940880701401169. Materials
(2007). News and Views: Industrial Services and Solutions at the Canadian Light Source. Synchrotron Radiation News 20(4) . 10.1080/08940880701510811. Materials
마르욜레인 키케르트; 브라이언 레너드 마크; 퓍 베르튄 카스테렌 반; ? 베르튄 카스테렌 반; 테렌스 윌리엄 제임스 et al. (2015). Arterivirus. Patent Number: KR20150060744A.
제임스 필립 오코넬; 존 로버트 포터; 알라스테어 로손; 트레이시 린 아라카키; 다니엘 존 라이트우드 et al. (2018). Antibody epitope. Patent Number: KR20180048571A.
아니쉬 수리; 스티븐 쉐리프; 수잰 수샤드; 애런 얌니욱; 스탠리 크라이스텍 et al. (2018). Antibody polypeptides that antagonize cd40. Patent Number: KR101905346B1.
아니쉬 수리; 스티븐 쉐리프; 수잰 수샤드; 애런 얌니욱; 스탠리 크라이스텍 et al. (2017). Antibody polypeptides that antagonize cd40. Patent Number: KR101734614B1.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 요한 프란손; 로빈 매튜 할렛; 모니카 파스쿠알 가르시아 et al. (2021). Combination of LIF inhibitor and PD-1 axis inhibitor for use in treating cancer. Patent Number: KR20210021287A.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 로빈 매튜 홀레트; 파트리샤 앤 깁린; 잔느 마그람 et al. (2021). Combination of LIF inhibitors and platinum-based anti-neoplastic agents for use in treating cancer. Patent Number: KR20210022065A.